NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,373 | +3.6% | 604 | +6.3% | 0.00% | – |
| Q2 2023 | $4,220 | +10450.0% | 568 | -90.2% | 0.00% | – |
| Q1 2023 | $40 | +100.0% | 5,800 | +205.3% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 1,900 | -36.7% | 0.00% | -100.0% |
| Q3 2022 | $62,000 | +1450.0% | 3,000 | +3348.3% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 87 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -99.2% | 87 | -99.0% | 0.00% | -100.0% |
| Q4 2021 | $799,000 | -74.3% | 8,524 | -43.1% | 0.01% | -68.4% |
| Q3 2021 | $3,106,000 | -4.5% | 14,981 | -2.2% | 0.02% | -5.0% |
| Q2 2021 | $3,252,000 | +3.0% | 15,319 | -12.1% | 0.02% | 0.0% |
| Q1 2021 | $3,158,000 | +51.7% | 17,419 | -6.7% | 0.02% | +53.8% |
| Q4 2020 | $2,082,000 | +122.4% | 18,669 | +116.0% | 0.01% | +62.5% |
| Q3 2020 | $936,000 | +2363.2% | 8,642 | +1799.3% | 0.01% | – |
| Q2 2020 | $38,000 | +660.0% | 455 | +19.7% | 0.00% | – |
| Q1 2020 | $5,000 | – | 380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |